VPCAT scholar Jewel Samadder, M.D., led a clinical trial finding a drug treatment that provides precision prevention for this group of high-risk patients. A combination of two drugs, sulindac (COX-2 inhibitor) and erlotnib (EGFR inhibitor), reduces precancerous polyps in the small intestine by 75 percent. ... Read More
Clinical Trials Support Foundation for Discovery
Population Health Foundation for Discovery
Precision Medicine Foundation for Discovery
Workforce Development Foundation for Discovery
What Is the Center for Clinical and Translational Science (CCTS)?
The CCTS is the home for clinical and translational science in our institution, the state of Utah, and within the Mountain West Region. It builds on the University of Utah Health Sciences’ strengths in genetics and bioinformatics to translate promising bench science into practices that improve human health.
The center serves as an academic home for clinical and translational research, developing innovative health services for the community and health researchers, and training a new generation of clinical and translational investigators. Four foundations of discovery compose the center: Clinical Trials Support, Population Health, Precision Medicine, and Workforce Development, and these foundations provide support for T1 to T4 research.
Applications due April 29, 2016. The purpose of the University of Utah Center for Clinical and Translational Science (CCTS) KL2 Mentored Career Development Scholar Award is to support the career development of junior faculty members who have made a commitment to focus their research endeavors on clinical or translational research.... Read More
Applications due May 2, 2016. The purpose of the University of Utah Center for Clinical and Translational Science (CCTS) KL2 Mentored Career Development Scholar Award is to support the career development of junior faculty members who have made a commitment to focus their research endeavors on clinical or translational research.... Read More
CCTS Precision Medicine Foundation partner, Recursion Pharmaceuticals, is profiled as a NCATS small business success story. Recursion has drawn from CCTS and Utah Genome Project's precisely phenotyped patient samples.... Read More
CCTS co-director, pediatrician, and infectious disease specialist Carrie Byington was elected to lead the U.S. Olympic Committee infectious disease advisory board to advise athletes and travelers who intend to go to the 2016 Olympic Games in Brazil... Read MorePediatrics
CCTS co-director Will Dere, M.D., and other University of Utah physicians and researchers spoke at the Rare Disease Day organized by Utah Rare... Read More
Vice President Joe Biden visited the Huntsman Cancer Institute at the University of Utah to consult with experts on the national "moonshot" initiative to eradicate cancer. The visit highlighted the power of CCTS Precision Medicine Foundation resources, Utah Population Database, and the Utah Genome Project, to uncover the genetic causes of diseasaes, including cancers. ... Read MoreHuman Genetics
Louisa Stark, Ph.D., key investigator with the CCTS Collaboration and Engagement Team, and director of the Genetic Science Learning Center (GSLC) was called to the White House Precision Medicine Initiative Summit to discuss her expertise.... Read MoreHuman Genetics
VPCAT scholar Rashmee Shah, M.D. , assistant professor of cardiology at the University of Utah School of Medicine leads a study finding that one-third of patients with cardiogenic shock die within 60 days of being discharged from the hospital.... Read MoreInternal Medicine